ยาเคมีบำบัดสูตร Trastuzumab -
THB 0.00
trastuzumab Intravenous trastuzumab is effective as a single-agent, and in combination with chemotherapy it significantly improves the median time to disease
For women with HER2-positive metastatic breast cancer, trastuzumab may be given on its own or with other treatments Treatment with trastuzumab trastuzumab Trastuzumab deruxtecan provides durable benefits to patients with heavily pretreated HER2
ปริมาณ:
trastuzumab Intravenous trastuzumab is effective as a single-agent, and in combination with chemotherapy it significantly improves the median time to disease
trastuzumab For women with HER2-positive metastatic breast cancer, trastuzumab may be given on its own or with other treatments Treatment with trastuzumab
Trastuzumab deruxtecan provides durable benefits to patients with heavily pretreated HER2